
ICON Public Limited Company ICLR
$ 183.72
-1.54%
Annual report 2024
added 12-06-2025
ICON Public Limited Company Cash Conversion Cycle 2011-2025 | ICLR
Annual Cash Conversion Cycle ICON Public Limited Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 62 | 74.2 | 58.1 | 53.1 | 78.5 | 142 | 145 | 132 | 129 | 137 | 132 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 145 | 53.1 | 104 |
Quarterly Cash Conversion Cycle ICON Public Limited Company
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 60.2 | - | 45.9 | 63.8 | 66.2 | - | 58.3 | 67.7 | 63.2 | - | 50.2 | 51.9 | 53.2 | - | 54.2 | 56.8 | 56.9 | - | 69.4 | 70.2 | 76.3 | - | 81.6 | 78.8 | 85.7 | - | 83.9 | 82.4 | 85.1 | - | 85.6 | 83.9 | 86.8 | - | 85 | 73.4 | 76 | - | 69.1 | 66.3 | 69.4 | - | 66.6 | 66.4 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 86.8 | 45.9 | 69.4 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
DarioHealth Corp.
DRIO
|
207 | $ 12.15 | 2.14 % | $ 345 M | ||
|
DexCom
DXCM
|
133 | $ 66.06 | -1.34 % | $ 25.5 B | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
Exact Sciences Corporation
EXAS
|
130 | $ 101.57 | 0.07 % | $ 18.8 B | ||
|
Burning Rock Biotech Limited
BNR
|
149 | $ 16.0 | 1.59 % | $ 172 M | ||
|
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
225 | $ 1.56 | -3.7 % | $ 1.98 M | ||
|
Castle Biosciences
CSTL
|
45.9 | $ 38.95 | 0.82 % | $ 1.08 B | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
83.5 | $ 227.29 | 0.42 % | $ 166 B | ||
|
Fulgent Genetics
FLGT
|
42.4 | $ 26.94 | -0.74 % | $ 815 M | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
63.7 | $ 1 408.65 | 1.08 % | $ 29.9 B | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
NeoGenomics
NEO
|
82.3 | $ 12.15 | 2.53 % | $ 1.54 B | ||
|
Neogen Corporation
NEOG
|
150 | $ 6.84 | -0.36 % | $ 1.48 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
76.4 | $ 19.9 | -3.21 % | $ 1.07 B | ||
|
Pacific Biosciences of California
PACB
|
149 | $ 2.12 | - | $ 538 M | ||
|
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
385 | $ 3.35 | -6.42 % | $ 107 K | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 26.46 | -0.62 % | $ 20 B | ||
|
Co-Diagnostics
CODX
|
299 | $ 0.3 | -13.39 % | $ 8.8 M | ||
|
Precipio
PRPO
|
-3.19 | $ 24.67 | -1.2 % | $ 32 M | ||
|
Quidel Corporation
QDEL
|
68.4 | $ 28.82 | 0.07 % | $ 1.21 B | ||
|
IQVIA Holdings
IQV
|
78 | $ 224.13 | 0.84 % | $ 40.6 B | ||
|
QIAGEN N.V.
QGEN
|
122 | $ 45.14 | -0.21 % | $ 10 B | ||
|
Guardant Health
GH
|
49.1 | $ 103.55 | 1.45 % | $ 12.7 B | ||
|
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M | ||
|
Sotera Health Company
SHC
|
37.3 | $ 16.76 | -0.42 % | $ 4.74 B | ||
|
Soleno Therapeutics
SLNO
|
63.2 | $ 49.79 | -4.25 % | $ 2 B | ||
|
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | ||
|
Thermo Fisher Scientific
TMO
|
69.8 | $ 574.27 | 0.46 % | $ 219 B | ||
|
Illumina
ILMN
|
142 | $ 134.66 | -0.16 % | $ 21.4 B | ||
|
Charles River Laboratories International
CRL
|
67.7 | $ 197.59 | 2.36 % | $ 10.2 B | ||
|
Trinity Biotech plc
TRIB
|
136 | $ 0.96 | -10.6 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
83.6 | $ 31.39 | 1.47 % | $ 1.88 B | ||
|
Quotient Limited
QTNT
|
345 | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
38.6 | $ 184.04 | 0.81 % | $ 20.4 B | ||
|
Biodesix
BDSX
|
41.7 | $ 7.63 | -2.8 % | $ 989 M | ||
|
Myriad Genetics
MYGN
|
45.1 | $ 7.07 | -2.01 % | $ 641 M |